Worthing
Available
A trial looking at MK-2870 for cancer of the womb (MK-2870-005)
This trial is comparing MK-2870 with chemotherapy for womb cancer that has come back after treatment.
A trial looking at different combinations of treatment for newly diagnosed myeloma (RADAR, Myeloma XV)
This trial is looking at bone marrow samples to help work out the best treatment for myeloma.
A trial looking at how often to give pembrolizumab for non small lung cancer (REFINE-Lung)
This trial is looking at whether it is possible to give pembrolizumab less often for advanced non small lung cancer.
A trial looking at acalabrutinib for Diffuse Large B Cell Lymphoma (REMoDL)
This trial is looking at giving acalabrutinib with chemotherapy for Diffuse Large B Cell Lymphoma (DLBCL).
A trial of venetoclax with low dose cytarabine for acute myeloid leukaemia (VICTOR)
This trial is comparing venetoclax and low dose cytarabine with intensive chemotherapy. It is for people with acute myeloid leukaemia aged 55 years and older.
A trial of ixazomib, lenalidomide and dexamethasone for people with myeloma (FITNEsS)
This trial is for people who might not be able to have the full dose of treatment because they have other illnesses or are not fit enough.
A trial comparing ruxolitinib with best available treatment for polycythaemia vera (MITHRIDATE)
This trial is comparing ruxolitinib with the best available treatment for people with high risk polycythaemia.
A trial of selinexor, cyclophosphamide and prednisolone for myeloma (MUK twelve)
This trial is for people whose myeloma has come back or treatment has stopped working.
A study looking at a new test called FIT to look for signs of bowel cancer (NICE FIT)
A study to see if the faecal immunohistochemistry test (FIT) can tell who needs to have a bowel test (colonoscopy) to check for bowel cancer.